ArticleGut2026

Repositioning dual GLP-1/GIP receptor agonists for the treatment of colitis and colitis-associated tumourigenesis.

Bianca N Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.